1.. Introduction {#S1}
================

Osteosarcoma, one of the most common forms of solid bone cancer in children and adolescents, often attack proximal humerus, proximal tibia and the metaphyseal regions of distal femur with high morbidity and mortality \[[@ref001]\]. Typical symptoms of osteosarcoma include joint movement limitation, trabecular fracture, local swelling and pain \[[@ref002]\]. The combination of surgery, post-operative radiotherapy and chemotherapy are the traditional therapies of osteosarcoma. Unfortunately, radiotherapy and chemotherapy usually result in some life-threatening side effects such as nephrotoxicity, infertility and cardiotoxicity. Therefore, it is important to understand the underlying molecular mechanism of tumorigenesis and explore a new therapy regime to prevent further deterioration of osteosarcoma.

More and more researches have demonstrated that microRNAs (miRNAs) are key predictors of the severity and prognosis of cancer. Studies over the last decades have indicated that a variety of abnormal miRNAs were existed in the pathogenesis of osteosarcoma \[[@ref003]\]. microRNA-511(miR-511) has been demonstrated to be dyregulated in diverse human cancer types including breast cancer \[[@ref004]\], colorectal cancer \[[@ref005]\], lung adenocarcinoma \[[@ref006]\]. However, whether miR-511 influences the progression of osteosarcoma remains unknown yet. The mitogen activated protein kinase (MAPK) signaling cascade are membrane-to-nucleus signaling modules and play important roles in multiple physiological processes \[[@ref007], [@ref008]\]. MAPK1 works as a downstream oncogene of MAPK signaling pathway. Furthermore, some previous studies suggested that MAPK1 was significantly up-regulated in various types of human cancers, such as ovarian cancer \[[@ref007]\], cervical cancer \[[@ref009]\] and gastric cancer \[[@ref010]\]. It is likely that MAPK1 also contributes to the development of osteosarcoma.

In Targetscan Website, we can see that the 3'UTR of MAPK1 is perfectly complementary with miR-511-3p. Therefore, we speculate that MAPK1 might be a target of miR-511-3p and restoring miR-511-3p expression may suppress osteosarcoma via targeting MAPK signaling pathway. In our research, we investigated the impact of miR-511 mimic on the proliferation and invasion of osteosarcoma and the potential molecular mechanisms *in vitro* and *in vivo*.

2.. Material and methods {#S2}
========================

2.1. Cell lines and cell culture {#S2.SS1}
--------------------------------

Osteosarcoma cell lines MG63, U-2 OS, Saos-2 and osteoblast hFOB1.19 cell lines were purchased from American Type Culture Collection (ATCC; Rockville, MD, USA). MG63 cells were cultured in Eagle's Minimum Essential Medium (EMEM; Gibco, Rockville, MD, USA) supplemented with 10% FBS. U-2 OS cells were cultured in McCoy's 5a Medium Modified supplemented with 10% FBS. Saos-2 cells were cultured in McCoy's 5a Medium Modified supplemented with 15% FBS. hFOB1.19 cells were kept in 1:1 mixture of Ham's F12 Medium Dulbecco's Modified Eagle's Medium, with 2.5 mM L-glutamine added 0.3 mg/ml G418 and 10% FBS. All cells except hFOB1.19 cells (34$^{\circ}$C) were kept at 37$^{\circ}$C in CO2 incubator.

2.2. Animals and ethics {#S2.SS2}
-----------------------

Nude mice (6--8 weeks old) were obtained from North Sichuan Medical College Affiliated Hospital. The experimental protocol was supported by the Committee on the Ethics of Animal Experiments of North Sichuan Medical College Affiliated Hospital.

2.3. Cell transfection {#S2.SS3}
----------------------

The interaction probability between miR-511 and MAPK1 was predicted by TargetScan. MiR-511 mimic wild type (wt), miR-511 mutant (mut) (Fig. [1](#cbm-26-cbm190534-g001){ref-type="fig"}A), mimic control, pcDNA-MAPK1 and pcDNA vector were obtained from GenePharma Co., Ltd (Shanghai, China). MG63 cells were transfected with pcDNA-MAPK1 (20 $\mu$g/mL)/pcDNA vector (20 $\mu$g/mL)/miR-511 (80 nM)/mimic control (160 nM)/pcDNA-MAPK1 (20 $\mu$g/mL) and miR-511 wt (40 nM or 80 nM)/ pcDNA-MAPK1 (20 $\mu$g/mL) and miR-511 mut (80 nM) using Lipofectamine 2000 (Invitrogen). The experimental protocol was performed strictly according to manufacturers' instruction. 48 h after transfection, cells were used for subsequent experiments.

2.4. Quantitative real-time polymerase chain reaction (qRT-PCR) {#S2.SS4}
---------------------------------------------------------------

Total RNA was extracted from cells cell lines (MG63, U2OS, SaOS2 and hFOB1.19) using TRIzol reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions. Equal amounts of RNA were reversely-transcribed to cDNA with SuperScript Reverse Transcriptase Kit (Vazyme, Nanjing, China). Then mRNA levels of miR-511 and MAPK1 were analyzed by SYBR Green PCR Master Mix (Vazyme) in a Fast Real-time PCR 7300 System (Applied Biosystems, Foster City, USA). Primers for MAPK1, miR-511-3p, snRNA U6 were synthesized by Sangon Bioteh (Shanghai, China). Data were analyzed according to the comparative Ct method also referred to as the 2$^{- {\Delta\Delta CT}}$ method. miR-511 was normalized to U6 and MAPK1 were normalized to $\beta$-actin.

2.5. Transwell assay {#S2.SS5}
--------------------

MG63 cells were seeded (5 $\times$ 10$^{4}$/200 $\mu$L) into the upper transwell chambers with serum-free EMEM. The lower chambers were filled with 500 $\mu$L 10% FBS EMEM. After 24-h incubation, cells in lower chambers were fixed in 95% ethanol, stained with hematoxylin. The number of cells was calculated and imaged under an inverted microscope (Olympus, Tokyo, Japan).

2.6. Matrigel tube formation assay {#S2.SS6}
----------------------------------

Matrigel tube formation assay was conducted as previous reported \[[@ref011]\]. When MG63 cell density reached to 90%, the growth medium was replaced by serum-free medium, and cells were incubated for 24 h at 37$^{\circ}$C. Conditional medium was subsequently collected and stored at $-$80$^{\circ}$C for subsequent tube formation assay. For the Matrigel tube formation assay, HUVECs (2 $\times$ 10$^{4}$) were seeded on Matrigel matrix separately with conditional medium, followed by incubation at 37$^{\circ}$C, 5% CO$_{2}$, for 12 h. After incubation for 8 h, photomicrographs were taken and the lengths of tubular structures were quantified by Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MA, USA).

2.7. BrdU staining {#S2.SS7}
------------------

The transfected cells were seeded into 24-well upper chamber (Corning, NY, USA) pre-coated with matrigel (BD, New Jersey, USA). The lower chamber was filled with RPMI-1640 medium containing 10% FBS. 24 h later, the invasive cells were stained with crystal violet (Sigma, MO, USA) for 15 min. Photos were taken under optical microscope (Olympus).

2.8. Western-blot assay {#S2.SS8}
-----------------------

After transfection for 48 h, the expressions of Ki67, cleaved caspase-3, vascular endothelial growth factor (VEGF), $\beta$-catenin, T-cell factor 4 (TCF4) and c-MYC (Abcam, Cambridge, UK) were measured using western-blot. GAPDH was used as the internal control. The experimental protocol was performed as described before \[[@ref012]\]. Immunoreactive bands were visualized by Chemiluminescent ECL Reagent Kit (Millipore, Bedford, MA, USA).

2.9. TOP/FOP-FLASH luciferase reporter assay {#S2.SS9}
--------------------------------------------

TOP/FOP-FLASH assay was performed as reported elsewhere \[[@ref013]\]. Briefly, transfected MG63 cells in each group were incubated with mixture containing serum-free DMEM (20 $\mu$L), $\beta$-catenin expression vector (1.5 $\mu$g), TCF4 expression vector (0.15 $\mu$g) and *Renilla* luciferase vector phRG-TK (0.8 ng). 24 h later, luciferase activity was measured by luminometer.

2.10. Osteosarcoma model and groups {#S2.SS10}
-----------------------------------

Nude mice were randomly divided into two groups ($n =$ 18). Control group: nude mice receiving subcutaneous injection of 2 $\times$ 10$^{6}$ MG63 cells transfected with vector; pcDNA-MAPK1 group: nude rat receiving subcutaneous injection of 2 $\times$ 10$^{6}$ MG63 cells transfected with pcDNA-MAPK1. Then, tumor volume was determined 5, 10, 15, 20, 25 and 30 days after injection using formula: volume $=$ length $\times$ width$^{2}$$\times$ 0.5. Percent survival was recorded at 3, 6, 9, 12, 15, 18, 21, 24, 27, 30 days after injection.

2.11. Immunohistochemical staining {#S2.SS11}
----------------------------------

3 $\mu$m thick tissue sections were prepared. After formalin fixation and paraffin embedding, tissue sections were submitted to standard immunohistochemistry protocols with anti-Ki67 and anti-VEGF. Pictures ($\times$ 400) were taken under optical microscope (Olympus).

2.12. HE staining {#S2.SS12}
-----------------

HE staining was performed for observation of tumor focal in lung and liver tissue of mice. Briefly, the lung and liver tissues were fixed in 10% neutral-buffered formalin, paraffin embedded, and sectioned at 4 mm thickness according to the standard procedure. The sections were deparaffinized and hydrated gradually, then examined by H&E staining.

2.13. Statistical analysis {#S2.SS13}
--------------------------

All statistical analyses were conducted using the SPSS statistical software program (version 17.0; SPSS, Inc., Chicago, IL, USA). The data presented in this study were expressed as means $\pm$ SD. Statistical differences were analyzed by one-way ANOVA. $P$ values $<$ 0.05 were considered statistically significant.

3.. Results {#S3}
===========

3.1. The expressions of miR-511 and MAPK1 were dysregulated in osteosarcoma cells {#S3.SS1}
---------------------------------------------------------------------------------

The binding sites between miR-511 and MAPK1 were shown in Fig. [1](#cbm-26-cbm190534-g001){ref-type="fig"}A via Targetscan website. As shown in Fig. [1](#cbm-26-cbm190534-g001){ref-type="fig"}B, the level of *miR-511* was decreased in osteosarcoma cells (MG63, U2OS and SaOS-2) compared with that in nonneoplastic cell (hFOB1.19) ($P <$ 0.05), especially in MG63 ($P <$ 0.01). Reversely, the expression of MAPK1 was tremendously increased in osteosarcoma cells (MG63, U2OS and SaOS-2) compared with hFOB1.19 group (Fig. [1](#cbm-26-cbm190534-g001){ref-type="fig"}C, $P <$ 0.05), especially in MG63 cells ($P <$ 0.01) .

Figure 1.The expression of miR-511 and MAPK1 were dysregulated in osteosarcoma cells. (A) The binding sites between miR-511 and MAPK1 were predicted via Targetscan website. The relative expressions miR-511(B) and MAPK1(C) were detected using RT-PCR in HFOB1.19, MG63, Saos2 and U2OS cell lines. $\beta$-actin was used as internal control. The experiments were repeated at least 3 times, and error bars represent $\pm$ SD ($$ 0.01, $$ 0.05 versus HFOB1.19 group).

3.2. MAPK1 is a target of miR-511 {#S3.SS2}
---------------------------------

As the results shown in Fig. [2](#cbm-26-cbm190534-g002){ref-type="fig"}A, miR-511 mimic transfection led to high expression level of miR-511, indicating the high transfection efficiency. Interestingly, miR-511 mimic transfection significantly reduced the mRNA level (Fig. [2](#cbm-26-cbm190534-g002){ref-type="fig"}B) and protein level (Fig. [2](#cbm-26-cbm190534-g002){ref-type="fig"}C and D) of MAPK1, which indicated that a reverse relationship was found in miR-511 and MAPK1. Luciferase reporter assay result shown in Fig. [2](#cbm-26-cbm190534-g002){ref-type="fig"}E suggested that miR-511 might target on MAPK1 and negatively regulate the expression of MAPK1.

Figure 2.MAPK1 is a target of miR-511. MG63 cells were randomly divided into 3 groups. Control group: normal MG63 cells; mimic NC group: MG63 cells were transfected with scramble mimics; miR-511 mimic group: MG63 cells were transfected with miR-511 mimic; The relative expressions miR-511(A) and MAPK1(B) were detected using RT-PCR in MG63 cells. $\beta$-actin was used as internal control. The experiments were repeated at least 3 times, and error bars represent $\pm$ SD ($$ 0.05 versus Control group). (C) The luciferase activity was detected in MG63 cells transfected with mimic control, mimic, miR-511 wt and miR-511 mut. The experiments were repeated at least 3 times, and error bars represent $\pm$ SD ($$ 0.05 versus the other 3 groups).

Figure 3.Up-regulated miR-511 inhibited the proliferation of MG63 cells. MG63 cells were randomly divided into 3 groups. Control group: normal MG63 cells; pcDNA-MAPK1 group: MG63 cells were transfected with pcDNA-MAPK1; vector group: MG63 cells were transfected with pcDNA. (A) The relative mRNA expression MAPK1 was detected using RT-PCR in MG63 cells. $\beta$-actin was used as internal control. (B) The relative protein expression MAPK1 was detected using western blot in MG63 cells. GAPDH was used as internal control. MG63 cells were randomly divided into 4 groups. Control group: normal MG63 cells; mimic: MG63 cells were transfected with miR-511 mimic; MAPK1 group: MG63 cells were transfected with pcDNA-MAPK1; MAPK1 $+$ mimic group: MG63 cells were transfected with pcDNA-MAPK1 and miR-511 mimic. (C) Cell proliferation was detected by BrdU staining (magnification, $\times$ 400). (D) The protein expressions were detected by western blot. GAPDH was used as internal control. The representative column diagrams showing results of relative protein expression ($$ 0.05, versus control group; \#$p <$ 0.05, compared with MAPK1 group).

Figure 4.Up-regulated miR-511 inhibited the invasion of MG63 cells. MG63 cells were randomly divided into 4 groups. Control group: normal MG63 cells; mimic: MG63 cells were transfected with miR-511 mimic; MAPK1 group: MG63 cells were transfected with pcDNA-MAPK1; MAPK1 $+$ mimic group: MG63 cells were transfected with pcDNA-MAPK1 and miR-511 mimic. (A) Cell invasion of MG63 was assayed by Transwell assay (magnification, $\times$ 400). (B&D) The relative protein expressions were detected by western blot in MG63 cells. GAPDH was used as internal control ($$ 0.05, versus control group; \#$p <$ 0.05, compared with MAPK1 group). (C) Tube formation assay. Photomicrographs were acquired with an inverted microscope (OLYMPUS).

3.3. Up-regulated miR-511 inhibited the proliferation of MG63 cells {#S3.SS3}
-------------------------------------------------------------------

As shown in Fig. [3](#cbm-26-cbm190534-g003){ref-type="fig"}A and B, relative mRNA and protein expressions were remarkably increased in MG63 cells transfected with pcDNA-MAPK1 compared with cells transfected with vector.

To determine the impact of miR-511 on the proliferation of MG63 cells, BrdU assay was used. As shown in Fig. [3](#cbm-26-cbm190534-g003){ref-type="fig"}C, cells in mimic group showed the reduced proliferative cells compared with control group ($P <$ 0.05), while cells in MAPK1 group exhibited increased proliferation compared with control group ($P <$ 0.05). MG63 cells transfected with both miR-511 mimic and pcDNA-MAPK1 showed a subdued effect. Furthermore, the expressions of proliferation markers PCNA and Ki67 were remarkably obstructed in mimic group compared control group, while expressions of PCNA and Ki67 were significantly upregulated in MAPK1 group ($P <$ 0.05). Importantly, the elevated expressions of PCNA and Ki67 induced by MAPK1 could be inhibited by miR-511 (Fig. [3](#cbm-26-cbm190534-g003){ref-type="fig"}D). These findings demonstrated that enhanced miR-511 suppressed the proliferation of MG63 cells through targeting MAPK1.

Figure 5.Up-regulated miR-511 suppressed the progression of osteosarcoma *in vivo*. Nude mice were randomly divided into 2 groups. Control group: tumor extracted from nude mice receiving subcutaneous injection of MG63 cells transfected with miR-NC; mimic group: tumor extracted from nude mice receiving subcutaneous injection of MG63 cells transfected with miR-511 mimic. (A) Gross tumor weight was detected. (B) The representative tumor images were exhibited. (C) The expressions of MAPK1 and miR-511 were evaluated using RT-PCR. (D) The levels of Ki67 and VEGF were detected by immunohistochemical assay. (E) The tumor focal lesions in liver/lung were detected by HE staining. The representative tumor images were exhibited. The experiments were repeated at least 3 times, and error bars represent $\pm$ SD ($$ 0.05, versus control group).

3.4. Up-regulated miR-511 inhibited the invasion of MG63 cells {#S3.SS4}
--------------------------------------------------------------

To determine the impact of miR-511 on the invasion of MG63 cells, Transwell assay was performed. As shown in Fig. [4](#cbm-26-cbm190534-g004){ref-type="fig"}A, cells in mimic group showed the reduced invasive cells compared with control group ($P <$ 0.05), while cells in MAPK1 group exhibited increased invasive compared with control group ($P <$ 0.05). MG63 cells transfected with both miR-511 mimic and pcDNA-MAPK1 showed a subdued effect. In addition, the Matrigel tube formation assay results suggest that miR-511 mimic inhibited neovascularization, while the MAPK1 promoted this activity (Fig. [4](#cbm-26-cbm190534-g004){ref-type="fig"}C, $P <$ 0.05). Furthermore, the expressions of VEGF and N-cadherin were decreased in mimic group compared control group, while increased in MAPK1 group ($P <$ 0.05). In contrary, the expression of E-cadherin was increased in mimic group compared control group, while decreased in MAPK1 group ($P <$ 0.05). Importantly, those expressions induced by MAPK1 could be restored by miR-511 (Fig. [4](#cbm-26-cbm190534-g004){ref-type="fig"}B--D). These findings demonstrated that enhanced miR-511 suppressed the invasion of MG63 cells through targeting MAPK1.

3.5. Up-regulated miR-511 suppressed the progression of osteosarcoma in vivo {#S3.SS5}
----------------------------------------------------------------------------

To validate miR-511 indeed play an anti-cancer role *in vivo*, tumor weight was detected. As displayed in Fig. [5](#cbm-26-cbm190534-g005){ref-type="fig"}A, the tumor weight was remarkably reduced in mimic group compared with control ($P <$ 0.05), the tumor image was shown as Fig. [5](#cbm-26-cbm190534-g005){ref-type="fig"}B. In addition, the level of miR-511 was tremendously up-regulated in mimic group compared with control group, while MAPK1 was vastly suppressed in mimic group compared with control group (Fig. [5](#cbm-26-cbm190534-g005){ref-type="fig"}C, $P <$ 0.05). Furthermore, the expressions of Ki67 and VEGF were remarkably reduced in mimic group compared with control group (Fig. [5](#cbm-26-cbm190534-g005){ref-type="fig"}D). Moreover, the HE staining of liver and lung showed that mimic reduced the empty focal lesions in liver/lung (Fig. [5](#cbm-26-cbm190534-g005){ref-type="fig"}E), which indicated that enhanced miR-511 expression restrained the metastasis osteosarcoma *in vivo*.

4.. Discussion {#S4}
==============

Osteosarcoma, a kind of highly aggressive and rapidly metastasizes cancer, arises from metaphysis of the long bones and produces immature bone \[[@ref014]\]. Despites many efforts have been taken in the available treatment of osteosarcoma, the effects are limited. The key to overcome osteosarcoma is to explore the molecules and signaling pathways associated with this disease.

MiRNAs is implicated in the regulation of gene expression a posttranscriptional level. A lot of studies have demonstrated the importance of miRNA in multiple human cancers \[[@ref015]\]. miR-511 is considered as a tumor suppressor in multiple cancers including lung cancer, prostate cancer \[[@ref016]\], gastric cancer \[[@ref017]\], gallbladder cancer \[[@ref018], [@ref019]\], hepatocellular carcinoma \[[@ref020]\] and colorectal cancer \[[@ref005]\] and only few reports showed that miR-511 served as a carcinogenic factor in other cancers, such as HCV-associated diffuse large B-cell lymphoma as well as in human blood monocyte-derived dendritic cells and macrophages \[[@ref021]\]. Interestingly, our study revealed that miR-511 was remarkably down-regulated in osteosarcoma MG63, SaOS2 and U2OS cells. Importantly, miR-511 was observed to inhibit cell proliferation, invasion of osteosarcoma cells and *in vivo* tumor growth by restoring miR-511 level (mimic). These results suggest that miR-511 acts as a tumor suppressor in osteosarcoma.

Researches revealed different targets of miR-511, such as AKT1, Insulin-like growth factor-1, Hepatoma-derived growth factor, TLR4, NO synthase 1 and TRIM24 \[[@ref005], [@ref018], [@ref022], [@ref023], [@ref024], [@ref025]\]. In present study, the interaction has been predicted in targetscan ([http://www. targetscan.org/cgi-bin/targetscan/vert_71/targetscan. cgi?species=Human&mir_nc=miR-511-3p](http://www. targetscan.org/cgi-bin/targetscan/vert_71/targetscan. cgi?species=Human&mir_nc=miR-511-3p)). In addition, the interaction between miR-511 and MAPK1 was further validated by luciferase reporter assay result in our study. we found that MAPK1 is up-regulated in osteosarcoma MG63, SaOS2 and U2OS cells, which is dramatically contrary with miR-511. Besides, the overexpression of MAPK1 counteracts the inhibitory effect of miR-511, which further improves the interaction between MAPK1 and miR-511. Furthermore, some previous studies suggested that MAPK1 was significantly up-regulated in various types of human cancer, such as breast cancer \[[@ref026]\], lung cancer \[[@ref027]\], and ovarian cancer \[[@ref028]\]. Herein, MAPK1 was demonstrated to be highly expressed and could be regulated by miR-511 in osteosarcoma. Also, MAPK1 is thought as a oncogene in osteosarcoma in this study. The carcinogenesis of MAPK1 can be confirmed by previous study \[[@ref026], [@ref027], [@ref028]\].

*In vivo*, we checked the role of miR-511 on tumor growth, MAPK1 expression, Ki67 and VEGF expression as well as in vivo metastasis in mice. The results show that restoring miR-511 level by mimic can significantly inhibit tumor growth and the expression of MAPK1, Ki67 and VEGF. Since osteosarcoma easily transfers to liver and lung. We checked whether the tumor transferred to lung or liver, consequently, miR-511 mimic reduced the metastasis of xenograft tumor.

In summary, this study demonstrated that over-expressed miR-511 obstructed tumorigenesis by targeting MAPK1 *in vitro*and *in vivo.* Considering the carcinogenic effect of MAPK1, it may be an effective therapeutic target for osteosarcoma. Besides that, miR-511 may be a potential biomarker for the diagnosis and prognosis of osteosarcoma.
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